23andMe Is Sinking Fast. Can the Company Survive?
23andMe is in trouble. Once a hot Silicon Valley startup, the genetic testing company has been in free fall since a major ...
Customer DNA at 23andMe will remain private for now; CEO no longer wants to sell to a third party
DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
Last year, 23andMe Holding Co. (NASDAQ:ME) said the company learned that a threat actor accessed several individual ...
23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows
Genetic testing firm 23andMe Chief Executive Officer Anne Wojcicki would no longer be open to considering third-party ...
23andMe's Anne Wojcicki now says her take-private plan is the best option for company
Anne Wojcicki, the cofounder and CEO of 23andMe, now says her plan to take the genetic testing company private is its "the ...
Remember That DNA You Gave 23andMe?
DNA might contain health information, but unlike a doctor’s office, 23andMe is not bound by the health-privacy law HIPAA. And ...
Could 23andMe $30 million data breach settlement get derailed by mass arbitration?
A law firm representing about 5,000 23andMe customers who demanded arbitration after hackers obtained sensitive data from the ...
bovnews14h
23andMe Holding Co. (ME) Stock: More Resilient Than It Appears
On Thursday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.39 which represents no change from the prior close of $0.39. The stock opened at $0.39 and touched a low of $0.37 ...
Boing Boing on MSN19h
23andme's prospects for survival dim
Genetic surveillance company 23andMe, once a $6bn prospect, is now a penny stock on the verge of doom. So "what happens to ...